Affinity Asset Advisors’s CytomX Therapeutics CTMX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-125,000	Closed	-$636K	–	51
2021 Q3	$636K	Buy	125,000 +50,000	+67%	+$254K	0.16%	60
2021 Q2	$475K	Buy	75,000 +25,000	+50%	+$158K	0.17%	59
2021 Q1	$387K	Buy	+50,000	New	+$387K	0.13%	58